|
|
|
1-10 employees
View all
|
|
Pharmaceuticals
|
|
5580 Morehouse Dr, Suite 120, San Diego, California 92121, US
|
|
After a technology spin-out from Nitto Denko Corporation (Japan’s leading diversified materials manufacturer), PassPort Technologies was established in San Diego, California, to continue R&D efforts towards the commercialization of improved pharmaceutical products using its patent-protected transdermal drug delivery platform (PassPort® System). The result is a unique drug repositioning opportunity for companies who already offer approved therapeutics, as well as those developing new NCE candidates that could benefit from alternative/improved routes of administration.
The novel PassPort® System combines microporation technology to painlessly create micropores on the skin surface and patch formulation technology that controls drug absorption through the micropores. By using the PassPort® System, it is now possible for transdermal needle-free administration of drugs that have previously been limited to injections or infusions. This platform is not only applicable to low molecular weight drugs but also for other modalities such as peptides, oligonucleotides and proteins.
|
PassPort Technologies, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used PassPort Technologies, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact PassPort Technologies, Inc. customer service number in your country click here to find.
Kentaro Kawata is the CEO of PassPort Technologies, Inc.. To contact Kentaro Kawata email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.